Andrew Lam, PharmD is an accomplished healthcare professional with a broad range of experience in investment banking, equity research, and medical affairs. He holds a Doctor of Pharmacy degree from Long Island University, a Master of Business Administration from Drexel University, and completed his undergraduate studies at Rutgers University. Andrew is currently serving as the Vice President of Healthcare Investment Banking at Jefferies, where he is responsible for leading strategic transactions and advising on mergers and acquisitions in the healthcare industry. Prior to Jefferies, he was a Senior Associate at BMO Capital Markets and an Associate at Canaccord Genuity Group Inc., where he focused on biotech equity research. Before transitioning to investment banking, Andrew also served in various medical affairs roles at Celgene and Shire, where he worked on developing treatments for rare diseases and hematology/oncology. Andrew's diverse background in both clinical and financial realms makes him a valuable asset to any team in the healthcare industry.